Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

164

currently held

Exits tracked

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-09-23

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks ago

Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Lauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month ago

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
Recode Therapeutics Leaps by Bayer	Biotech	United States	Leaps by Bayer	2022	4yr	Active	–	–
Revel Pharmaceuticals KIZOO Evergreen (Balance Sheet)	Biotech	United States	KIZOO Technology Capital	2020	6yr	Active	–	–
RevivBio Health for Life Capital II	Biotech	United States	Seventure Partners	2023	3yr	Active	–	–
Rgenta Boehringer Ingelheim Venture Fund	Biotech	United States	Boehringer Ingelheim Venture Fund	2019	7yr	Active	–	–
Seaport Therapeutics General Atlantic	Biotech	United States	General Atlantic	–	–	Active	–	–
Siolta Therapeutics Health for Life Capital	Biotech	United States	Seventure Partners	2020	6yr	Active	–	–
SonoThera Leaps by Bayer	Biotech	United States	Leaps by Bayer	2026	0yr	Active	–	–
Spiral Therapeutics Inveready Biotech II	Biotech	United States	Inveready Asset Management	2019	7yr	Active	–	–
STRM.BIO Boehringer Ingelheim Venture Fund	Biotech	United States	Boehringer Ingelheim Venture Fund	2021	5yr	Active	–	–
TR1X Neva First	Biotech	United States	Neva SGR	2022	4yr	Active	–	–
Transcripta Bio BlueYard Capital Fund II	Biotech	United States	BlueYard Capital	2020	6yr	Active	–	–
TRexBio SV Life Sciences Fund VI	Biotech	United States	SV Health Managers	2018	8yr	Active	–	–
Triumvira Therapeutics Leaps by Bayer	Biotech	United States	Leaps by Bayer	2020	6yr	Active	–	–
Van Heron Labs FoodLabs Fund II	Biotech	United States	FoodLabs	2024	2yr	Active	–	–
Vedanta Health for Life Capital	Biotech	United States	Seventure Partners	2020	6yr	Active	–	–
Ventus Therapeutics TVM Life Science Ventures	Biotech	United States	TVM Capital Life Science	2020	6yr	Active	–	–
Verdiva Bio General Atlantic Growth Equity Fund	Biotech	United States	General Atlantic	–	–	Active	–	–
Vertero... Health for Life Capital	Biotech	United States	Seventure Partners	2023	3yr	Active	–	–
Violet Therapeutics Dementia Discovery Fund 2	Biotech	United States	SV Health Managers	2023	3yr	Active	–	–
X-Therma LIFTT	Biotech	United States	LIFTT	2024	2yr	Active	–	–
Modern Synthesis3 periods Extantia Flagship	Biotech	United States	Extantia Capital	2022	4yr	Active	–	–
Hillstar Bio2 periods LifeArc Ventures	Biotech	United States	LifeArc	2023	3yr	Active	–	–
Nuvig Therapeutics2 periods Leaps by Bayer	Biotech	United States	Leaps by Bayer	2022	4yr	Active	–	–
Solve Therapeutics2 periods Abingworth Bioventures 8	Biotech	United States	Abingworth	2025	1yr	Active	–	–
Tolerance Bio2 periods Columbus Life Sciences Fund IV	Biotech	United States	Columbus Venture Partners	2024	2yr	Active	–	–
Aether Bio Henkel Ventures Balance-Sheet Vehicle	Biotech	United States	Henkel Ventures	2025	1yr	Active	–	–
Affini-T Therapeutics Leaps by Bayer	Biotech	United States	Leaps by Bayer	2022	4yr	Active	–	–
Alba Therapeutics Corp HealthCap V	Biotech	United States	HealthCap	2005	21yr	Active	–	–
Anciata Therapeutics, Inc. TVM Life Science Innovation	Biotech	United States	TVM Capital Life Science	2025	1yr	Active	–	–
Antheia Athos Evergreen Life Sciences	Biotech	United States	Athos	2025	1yr	Active	–	–
Arclight Therapeutics Angelini Ventures	Biotech	United States	Angelini Ventures	2022	4yr	Active	–	–
Aristea Therapeutics Novo Holdings Venture Investments	Biotech	United States	Novo Holdings	2021	5yr	Active	–	–
Aro Biotherapeutics HealthCap VIII	Biotech	United States	HealthCap	2021	5yr	Active	–	–
ArrePath Boehringer Ingelheim Venture Fund	Biotech	United States	Boehringer Ingelheim Venture Fund	2021	5yr	Active	–	–
Arriva Pharmaceuticals Nordic Biotech II K/S	Biotech	United States	Nordic Biotech Advisors	2008	18yr	Active	–	–
Auricula Biosciences TVM Life Science Innovation	Biotech	United States	TVM Capital Life Science	2022	4yr	Active	–	–
Avalyn Novo Holdings Venture Investments	Biotech	United States	Novo Holdings	2017	9yr	Active	–	–
AvenCell Novo Holdings Growth Investments	Biotech	United States	Novo Holdings	2024	2yr	Active	–	–
Bambusa Therapeutics Athos Evergreen Life Sciences	Biotech	United States	Athos	2025	1yr	Active	–	–
Beren Therapeutics Wellington Partners Life Sciences	Biotech	United States	Wellington Partners	2026	0yr	Active	–	–
Biomilq Green Generation Fund I	Biotech	United States	Green Generation Fund	2021	5yr	Active	–	–
Biotheus General Atlantic Growth Equity Fund	Biotech	United States	General Atlantic	–	–	Active	–	–
Claris Bio Novo Holdings Seed Investments	Biotech	United States	Novo Holdings	2019	7yr	Active	–	–
Claris Biotherapeutics Novo Holdings Venture Investments	Biotech	United States	Novo Holdings	2026	0yr	Active	–	–
Clasp Therapeutics Novo Holdings Venture Investments	Biotech	United States	Novo Holdings	2023	3yr	Active	–	–
Cloverleaf Bio 4BIO Ventures III	Biotech	United States	4Bio Partners	2026	0yr	Active	–	–
Convergent Novo Holdings Growth Investments	Biotech	United States	Novo Holdings	2024	2yr	Active	–	–
Coultreon Biopharma Novo Holdings Seed Investments	Biotech	United States	Novo Holdings	2026	0yr	Active	–	–
Cour Pharmaceuticals Angelini Ventures	Biotech	United States	Angelini Ventures	2023	3yr	Active	–	–
Crystalys Therapeutics Novo Holdings Venture Investments	Biotech	United States	Novo Holdings	2024	2yr	Active	–	–

Portfolio companies.34,000+ PE-backed.

Portfolio companies.
34,000+ PE-backed.